Celsion Corporation Announces Thermodox Abstract Accepted For Presentation At The American Society Of Clinical Oncology 2010 Annual Meeting
Source: Medical News Today
Friday 19th March, 2010
Celsion Corporation ( CLSN) announced that an abstract about the Phase I/II trial of ThermoDox® in Recurrent Chest Wall Cancer (RCW) has been accepted for presentation at the American Society of C... ...
Read the full story at
Medical News Today
Email this story to a friend
Have your say on this story